NHS Framework Agreement for Aseptically Prepared Cytotoxic Medicines and Monoclonal Antibodies for the Treatment of Cancer (Lots 1, 2, 3, 4 and 5)
Estimated value
£608.0m
Awarded value
£608.0m
Awarded 11 Mar 2024
Suppliers
1
Lots
1
1 awarded
Published
03 Apr 2024
Deadline 01 Dec 2023
Awarded suppliers· 1 supplier
Awarded 11 Mar 2024 · Contract period 31 Mar 2024 — 30 Mar 2028
Award value
£608.0m